Table of Contents Author Guidelines Submit a Manuscript
Emergency Medicine International
Volume 2015, Article ID 283021, 8 pages
http://dx.doi.org/10.1155/2015/283021
Research Article

New Insights into the Role of Metformin Effects on Serum Omentin-1 Levels in Acute Myocardial Infarction: Cross-Sectional Study

Department of Clinical Pharmacology and Therapeutic, College of Medicine, Al-Mustansiriya University, P.O. Box 14132, Baghdad, Iraq

Received 8 June 2015; Revised 23 October 2015; Accepted 3 November 2015

Academic Editor: Wen-Jone Chen

Copyright © 2015 Hayder M. Alkuraishy and Ali I. Al-Gareeb. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Lago, C. Dieguez, J. Gómez-Reino, and O. Gualillo, “The emerging role of adipokines as mediators of inflammation and immune responses,” Cytokine & Growth Factor Reviews, vol. 18, no. 3-4, pp. 313–325, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. C. M. De Souza Batista, R.-Z. Yang, M.-J. Lee et al., “Omentin plasma levels and gene expression are decreased in obesity,” Diabetes, vol. 56, no. 6, pp. 1655–1661, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Kazama, T. Usui, M. Okada, Y. Hara, and H. Yamawaki, “Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells,” European Journal of Pharmacology, vol. 686, no. 1–3, pp. 116–123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Cherian, N. P. Sudheesh, K. K. Janardhanan, and G. Patani, “Free-radical scavenging and mitochondrial antioxidant activities of Reishi-Ganoderma lucidum (curt: Fr) P. Karst and arogyapacha-Trichopus zeylanicus gaertn extracts,” Journal of Basic and Clinical Physiology and Pharmacology, vol. 20, no. 4, pp. 289–307, 2009. View at Google Scholar · View at Scopus
  5. P. Yan, L. Li, M. Yang et al., “Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 92, no. 3, pp. 368–374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. F.-J. Shang, J.-P. Wang, X.-T. Liu et al., “Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome,” Biomarkers, vol. 16, no. 8, pp. 657–662, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Dilip, S. Cholamugath, M. Baby, and D. Pattani, “Prevalence of cardiovascular risk factors and management practices of acute coronary syndrome in a tertiary care hospital,” Journal of Basic & Clinical Pharmacology, vol. 26, no. 6, pp. 547–554, 2015. View at Publisher · View at Google Scholar
  8. D. M. Ouwens, H. Sell, S. Greulich, and J. Eckel, “The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease,” Journal of Cellular and Molecular Medicine, vol. 14, no. 9, pp. 2223–2234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Krupinski, A. Font, A. Luque, M. Turu, and M. Slevin, “Angiogenesis and inflammation in carotid atherosclerosis,” Frontiers in Bioscience, vol. 13, no. 17, pp. 6472–6482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Šenolt, M. Polanská, M. Filková et al., “Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 7, pp. 1410–1411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. M. Mathew and K. Rajiah, “Assessment of medication adherence in type-2 diabetes patients on poly pharmacy and the effect of patient counseling given to them in a multispecialty hospital,” Journal of Basic and Clinical Pharmacy, vol. 5, no. 1, pp. 15–18, 2014. View at Publisher · View at Google Scholar
  12. K. G. Acharya, K. N. Shah, N. D. Solanki, and D. A. Rana, “Evaluation of antidiabetic prescriptions, cost and adherence to treatment guidelines: a prospective, cross-sectional study at a tertiary care teaching hospital,” Journal of Basic and Clinical Pharmacy, vol. 4, no. 4, pp. 82–87, 2013. View at Publisher · View at Google Scholar
  13. The Criteria Committee of the New York Heart Association, Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, Little, Brown and Company, Boston, Mass, USA, 9th edition, 1994.
  14. R.-Z. Yang, M.-J. Lee, H. Hu et al., “Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action,” American Journal of Physiology—Endocrinology and Metabolism, vol. 290, no. 6, pp. E1253–E1261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Yamawaki, S. Kameshima, T. Usui, M. Okada, and Y. Hara, “A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells,” Biochemical and Biophysical Research Communications, vol. 423, no. 1, pp. 152–157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Yamawaki, J. Kuramoto, S. Kameshima, T. Usui, M. Okada, and Y. Hara, “Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells,” Biochemical and Biophysical Research Communications, vol. 408, no. 2, pp. 339–343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Zhong, H.-Y. Zhang, H. Tan et al., “Association of serum omentin-1 levels with coronary artery disease,” Acta Pharmacologica Sinica, vol. 32, no. 7, pp. 873–878, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Yang and J. Lee, “Omentin a novel adipokine in human adipose tissue,” American Journal of Physiology: Endocrinology and Metabolism, vol. 290, no. 6, pp. 1253–1281, 2008. View at Google Scholar
  19. H. Xie, P.-L. Xie, X.-P. Wu et al., “Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression,” Cardiovascular Research, vol. 92, no. 2, pp. 296–306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. B. K. Tan, R. Adya, S. Farhatullah et al., “Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome. Ex vivo in vivo regulation of omentin-1 by insulin and glucose,” Diabetes, vol. 57, no. 4, pp. 801–808, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Vu, M. S. Sidhom, B. C. Bredbeck, L. A. Kosmiski, and C. L. Aquilante, “Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease,” Diabetology & Metabolic Syndrome, vol. 6, article 4, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. H. J. Yoo, S. Y. Hwang, H. C. Hong et al., “Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes,” Cardiovascular Diabetology, vol. 10, article 103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Tsutamoto, T. Tanaka, H. Sakai et al., “Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure,” European Heart Journal, vol. 28, no. 14, pp. 1723–1730, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Narumi, T. Watanabe, S. Kadowaki et al., “Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure,” Cardiovascular Diabetology, vol. 13, article 84, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Brunetti, S. Leone, G. Orlando et al., “Hypotensive effects of omentin-1 related to increased adiponectin and decreased interleukin-6 in intra-thoracic pericardial adipose tissue,” Pharmacological Reports, vol. 66, no. 6, pp. 991–995, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Wal, A. Wal, V. R. Nair, A. K. Rai, and U. Pandey, “Management of coronary artery disease in a Tertiary Care Hospital,” Journal of Basic and Clinical Pharmacy, vol. 4, no. 2, pp. 31–35, 2013. View at Publisher · View at Google Scholar
  27. U. A. Michael, B. U. David, C. O. Theophine, F. U. Philip, A. M. Ogochukwu, and V. A. Benson, “Antidiabetic effect of combined aqueous leaf extract of vernonia amygdalina and metformin in rats,” Journal of Basic and Clinical Pharmacy, vol. 1, no. 3, pp. 197–202, 2010. View at Google Scholar
  28. R. Krysiak, A. Gdula-Dymek, and B. Okopień, “Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance,” Pharmacological Reports, vol. 65, no. 1, pp. 208–213, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Kabil Kucur, I. Gozukara, A. Aksoy et al., “How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?” Blood Coagulation and Fibrinolysis, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Batchuluun, T. Inoguchi, N. Sonoda et al., “Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells,” Atherosclerosis, vol. 232, no. 1, pp. 156–164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. A. A. Agarwal, P. R. Jadhav, and Y. A. Deshmukh, “Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients,” Journal of Basic and Clinical Pharmacy, vol. 5, no. 3, p. 79, 2014. View at Publisher · View at Google Scholar
  32. T. M. D. Nguyen, F. Seigneurin, P. Froment, Y. Combarnous, and E. Blesbois, “The 5′-AMP-activated protein kinase (AMPK) is involved in the augmentation of antioxidant defenses in cryopreserved chicken sperm,” PLoS ONE, vol. 10, no. 7, Article ID e0134420, 2015. View at Publisher · View at Google Scholar
  33. F. Farshad, S. Gloria, P. Nikolay, and X. Shiqin, “Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis,” Journal of the American Heart Association, vol. 3, no. 6, Article ID e001202, 2014. View at Publisher · View at Google Scholar
  34. S. Meng, J. Cao, Q. He et al., “Metformin activates AMP-activated protein kinase by promoting formation of the αβγ heterotrimeric complex,” The Journal of Biological Chemistry, vol. 290, no. 6, pp. 3393–3802, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Baus, K. Heermeier, M. De Hoop et al., “Identification of a novel AS160 splice variant that regulates GLUT4 translocation and glucose-uptake in rat muscle cells,” Cellular Signalling, vol. 20, no. 12, pp. 2237–2246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. W.-H. Feng, X.-W. Yuan, G.-Y. Tong et al., “Correlated increase of omentin-1 and adiponectin by exenatide, avandamet and dietary change in diet-induced obese rats,” Folia Biologica, vol. 59, no. 6, pp. 217–224, 2013. View at Google Scholar · View at Scopus
  37. S.-N. Li, X. Wang, Q.-T. Zeng et al., “Metformin inhibits nuclear factor κB activation and decreases serum high-sensitivity C-reactive protein level in experimental atherogenesis of rabbits,” Heart and Vessels, vol. 24, no. 6, pp. 446–453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. V. De Leo, A. La Marca, R. Orvieto, and G. Morgante, “Effect of metformin on insulin-like growth factor (IGF) I and IGF-binding protein I in polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 4, pp. 1598–1600, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Preiss, S. M. Lloyd, I. Ford et al., “Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial,” The Lancet Diabetes and Endocrinology, vol. 2, no. 2, pp. 116–124, 2014. View at Publisher · View at Google Scholar · View at Scopus